Open Access
01.12.2021 | COVID-19 | Research Letter
The application of an oxygen mask, without supplemental oxygen, improved oxygenation in patients with severe COVID-19 already treated with high-flow nasal cannula
verfasst von:
Besarta Dogani, Fredrik Månsson, Fredrik Resman, Hannes Hartman, Johan Tham, Gustav Torisson
Hypoxemia is the clinical hallmark of severe COVID-19 infection, and guidelines suggest using high-flow nasal cannula (HFNC) when conventional oxygen therapy fails [1, 2]. In late 2020, we observed that oxygenation could be improved in some patients by applying a mask (e.g. a nebulisation mask or simple oxygen mask) to ongoing HFNC. This procedure has quickly become a clinical routine at our hospital, and in this study, we aim to assess its effect.
Anzeige
The study was performed at Skåne university hospital in Malmö, Sweden. Eligibility criteria were (1) COVID-19 infection, (2) HFNC treatment, and (3) estimated PaO2/FiO2 ratio of ≤ 13 kPa (~ 97.5 mmHg). Baseline measurements, including arterial blood gases (ABG), were taken without mask. Then, a simple oxygen mask was applied over nose and mouth for 30 min, without supplemental oxygen, followed by another ABG. Patients maintained position and HFNC settings throughout the procedure, which was monitored by a study physician. After mask removal, SpO2 was recorded upon reaching steady state and participants could continue using the mask at their doctor’s discretion. The primary outcome was change in SaO2, with hypothesis testing through a paired t test. Secondary outcomes included changes in PaCO2, SpO2 and respiratory rate.
Eighteen patients were included, see Table 1. SaO2 (%) was higher in all patients after 30 min with mask than at baseline, mean difference: 5.1% (95%CI 3.0–7.2%), see Fig. 1a. There was a trend towards increased PaCO2, mean difference: 0.15 (95%CI − 0.03 to 0.34) KPa, see Fig. 1b. SpO2 increased with mask and decreased after mask removal, see Fig. 1c. Mean respiratory rate was 22.4 with mask, compared to 24.6 at baseline, mean difference: − 2.2, (95%CI − 0.2 to − 4.2).
Table 1
Patient and infection characteristics at the time of inclusion
N = 18
Age
69 (61–75)
Male sex
13 (72%)
Smoking history
10 (56%)
Diabetes
3 (17%)
Hypertension
11 (61%)
Chronic pulmonary disease
4 (22%)
Immunosuppression
3 (17%)
Charlson index ≥ 2points
6 (33%)
Body mass index
< 25
3 (17%)
25–30
8 (44%)
30–35
1 (6%)
35 +
6 (33%)
Infection characteristics
Symptom duration, days
13 (10–14)
Respiratory rate/minute
24 (21–28)
Heart rate/minute
69.5 (64–87)
MAP, mmHg
90 (84–103)
PaO2, KPa/mmHg
8.1 (7.0–8.8) / 61 (53–66)
Estimated P/F ratio, KPa/mmHg
9.8 (8.4–10.5) / 74 (63–79)
c-Reactive protein, mg/L
74 (41–111)
Neutrofile/lymphocyte ratio
12 (7–21)
Procalcitonin, μg/L
0.2 (0.1–0.3)
Ferritin, μg/L
1085 (752–1683)
d-Dimer, mg/L
1.9 (0.8–3.6)
Troponin, ng/L
12 (9–21)
Pro-BNP, ng/L
466 (235–1197)
Creatinine, µmol/L
65 (59–73)
Treatment
Betametasone
18 (100%)
LMWH
18 (100%)
Remdesivir
1 (6%)
Antibiotics
6 (33%)
HFNC flow, L/min
40 (40–40)
FiO2, %
82.5% (80–100)
Position (side/back/prone)
9/4/5
HFNC/NIV ceiling of care
4 (22%)
Data are presented as median (IQR) or count (%). For Charlson index, the updated version (Quan 2011) was used
Outcome. Mean oxygen saturation from arterial blood (SaO2) at baseline and with mask (a). Mean partial pressure of carbon dioxide (PaCO2) at baseline and with mask (b). Mean peripheral saturation from pulsoximetry (SpO2) at baseline, with mask and after mask removal (c) error bars = 95% confidence interval of the mean. *** = p < .001 from two-sided paired t test. Paired nonparametric tests were also performed to test robustness, with a similar degree of statistical significance (p < .001)
×
Thus, this small study confirmed the observation that oxygenation improved when a mask was added to HFNC. PaCO2 increased slightly, possibly due to a lower respiratory rate, but without hypercapnia. No other side effects or complications were observed during this short-term study. The decline of SpO2 after mask removal suggested an intervention effect, although SpO2 did not fully reach baseline levels. The underlying mechanism was not studied, but we hypothesise that the mask could minimise entrainment of room air, especially when mouth-breathing.
Our HFNC device had a maximum flow rate of 40 L/min. However, the increase in SaO2 of 5% is in line with the 4% found in a study with a similar design but another HFNC device and a flow rate of 60 L/min [3]. Furthermore, this other study used a surgical mask, suggesting that the observed phenomenon is neither strictly mask- nor device-dependent. The study populations of these two small studies were quite similar though, and the generalisability of the results must be considered uncertain at this point.
Anzeige
Optimal intubation timing in COVID-19 is debated [4‐6]. At our hospital, patients with severe hypoxemia have increasingly been managed for long periods on non-invasive respiratory support, including awake proning. In this context, the intermittent use of mask + HFNC (alternating with proning, during mobilisation, as a rescue in desaturation episodes, a bridge to intubation or a last resort for patients with ceiling of care) has filled a niche, being less demanding than NIV by face mask, while maintaining benefits of HFNC over conventional oxygen treatment. However, without experienced staff, rigorous monitoring and intubation protocols, adding a mask to HFNC could also delay intubation, putting the patient at risk.
In conclusion, further studies are needed regarding oxygen delivery in severe COVID-19. The results in this study suggest that the addition of a mask to HFNC could improve oxygenation in some patients in the short-term perspective. However, potential long-term risks, including those associated with delaying intubation, must be acknowledged.
Acknowledgements
The authors thank Katja Beskow for assistance in data acquisition.
Declarations
Ethics approval and consent to participate
All patients provided informed consent and the study was approved by the Swedish Ethical Review Authority (2020-07078 and 2021-00834).
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Availability of data and materials
Data are available on reasonable request to the corresponding author.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The application of an oxygen mask, without supplemental oxygen, improved oxygenation in patients with severe COVID-19 already treated with high-flow nasal cannula
verfasst von
Besarta Dogani Fredrik Månsson Fredrik Resman Hannes Hartman Johan Tham Gustav Torisson
Wer ihn je erlebt hat, wird ihn nicht vergessen: den Schmerz, den die beim Öffnen oder Schließen des Reißverschlusses am Hosenschlitz eingeklemmte Haut am Penis oder Skrotum verursacht. Eine neue Methode für rasche Abhilfe hat ein US-Team getestet.
Der optimale Ansatz für die Blutdruckkontrolle bei Patientinnen und Patienten mit akutem Schlaganfall ist noch nicht gefunden. Ob sich eine frühzeitige Therapie der Hypertonie noch während des Transports in die Klinik lohnt, hat jetzt eine Studie aus China untersucht.
Zwar scheint es laut einer Studie aus den USA und Kanada bei der Reanimation von Kindern außerhalb einer Klinik keinen Unterschied für das Überleben zu machen, ob die Wiederbelebungsmaßnahmen während des Transports in die Klinik stattfinden oder vor Ort ausgeführt werden. Jedoch gibt es dabei einige Einschränkungen und eine wichtige Ausnahme.
Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.
Update AINS
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.
